Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Nov 02, 2023 6:47pm
114 Views
Post# 35714770

RE:Confidence in your own strength?

RE:Confidence in your own strength?do insiders have any confidence that CEAPRO can execute any of the following?

a. a commerical PGX CoQ10 in H2 2023 or even H1 2024
b. a partnership deal of any type that will result in those "milestone" payments that were talked about years ago
c. revenue recovery of their base business despite SYMRISE as a direct competitor
d. successuful AV trial, Y-BG trials in 2024, or other product developments as catalysts for the share price

"in a nutshell" ; 

if the answer is yes, we haven't seen any insider buying ...

if the answer is no, then we need a change in leadership with a CEO who can execute and monetize what we hear is a disruptive technology (PGX), a delivery system which has a "plethora" of applications
<< Previous
Bullboard Posts
Next >>